Journal of Pathology

Papers
(The H4-Index of Journal of Pathology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Artificial intelligence to identify genetic alterations in conventional histopathology97
Escape from senescence: molecular basis and therapeutic ramifications85
CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment79
A new FGF15/19‐mediated gut‐to‐heart axis controls cardiac hypertrophy74
Integration of peripheral blood‐ and tissue‐based biomarkers of response to immune checkpoint blockade in urothelial carcinoma73
Issue Information67
Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells66
Spatial profiling of ANO7 in prostate tissue: links to AR‐signalling‐associated lipid metabolism and inflammation63
Breathing in danger: how particulate matter pollution is putting the public at risk of lung cancer60
Ovarian high‐grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance58
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities56
The association between the tumor immune microenvironments and clinical outcome in low‐grade, early‐stage endometrial cancer patients52
‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors51
Intravenous iron treatment fuels chronic kidney disease‐induced arterial media calcification in rats50
High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer46
Presence of Tim3+ and PD‐1+CD8+T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and di45
Identification of actionable targets using DEPArray ‐based sorting of pure carcinoma and stromal populations from formalin‐fixed paraffin‐embedded ti45
Field cancerization in breast cancer44
CRISPR –Cas9 screening identifies the role of FER as a tumor suppressor41
41
Identification of tumour‐infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma40
Silencing GRHL3 promotes multiple organ distant metastasis of lung squamous cell carcinoma cells by enhancing SOX2 stability via SIRT140
Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response37
In high‐grade ovarian carcinoma, platinum‐sensitive tumor recurrence and acquired‐resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and 37
The E2F1–HOXB9/PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer37
Pseudobudding: ruptured glands do not represent true tumor buds36
Human scattered tubular cells represent a heterogeneous population of glycolytic dedifferentiated proximal tubule cells35
Integrating computational pathology and proteomics to address tumor heterogeneity33
KMT2D deficiency potentiates antitumor immunity and sensitizes immune checkpoint blockade in urologic cancers33
Genomic features of Helicobacter pylori‐naïve diffuse‐type gastric cancer33
33
Development of a multi‐scanner facility for data acquisition for digital pathology artificial intelligence32
0.25358986854553